Role of IL-21 in inflammatory bowel disease

References

• Abraham C, Cho JH. Inflammatory bowel disease. N. Engl. J. Med.361(21), 2066–2078 (2009).
   PubMed Web of Science ®Google Scholar
• Monteleone G, Caprioli F. T-cell-directed therapies in inflammatory bowel diseases. Clin. Sci. (Lond.)118(12), 707–715 (2010).
   PubMed Web of Science ®Google Scholar
• Monteleone G, Biancone L, Marasco R et al. Interleukin 12 is expressed and actively released by Crohn’s disease intestinal lamina propria mononuclear cells. Gastroenterology112(4), 1169–1178 (1997).
   PubMed Web of Science ®Google Scholar
• Neurath MF, Weigmann B, Finotto S et al. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn’s disease. J. Exp. Med.195(9), 1129–1143 (2002).
   PubMed Web of Science ®Google Scholar
• Fuss IJ, Neurath M, Boirivant M et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol.157(3), 1261–1270 (1996).
   PubMed Web of Science ®Google Scholar
• Fuss IJ, Heller F, Boirivant M et al. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J. Clin. Invest.113(10), 1490–1497 (2004).
   PubMed Web of Science ®Google Scholar
• Heller F, Florian P, Bojarski C et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology129(2), 550–564 (2005).
   PubMed Web of Science ®Google Scholar
• Fujino S, Andoh A, Bamba S et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut52(1), 65–70 (2003).
   PubMed Web of Science ®Google Scholar
• Sarra M, Pallone F, Macdonald TT, Monteleone G. IL-23/IL-17 axis in IBD. Inflamm. Bowel Dis. DOI: 10.1002/ibd.21248 (2010) (Epub ahead of print).
   Google Scholar
• Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu. Rev. Immunol.20, 495–549 (2002).
   PubMed Web of Science ®Google Scholar
• Parrish-Novak J, Dillon SR, Nelson A et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature408(6808), 57–63 (2000).
   PubMed Web of Science ®Google Scholar
• Coquet JM, Kyparissoudis K, Pellicci DG et al. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J. Immunol.178(5), 2827–2834 (2007).
   PubMed Web of Science ®Google Scholar
• Chtanova T, Tangye SG, Newton R et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J. Immunol.173(1), 68–78 (2004).
   PubMed Web of Science ®Google Scholar
• Vogelzang A, McGuire HM, Yu D et al. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity29(1), 127–137 (2008).
   PubMed Web of Science ®Google Scholar
• Zhou L, Ivanov, II, Spolski R et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol.8(9), 967–974 (2007).
   PubMed Web of Science ®Google Scholar
• Korn T, Bettelli E, Gao W et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature448(7152), 484–487 (2007).
   PubMed Web of Science ®Google Scholar
• Nurieva R, Yang XO, Martinez G et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature448(7152), 480–483 (2007).
   PubMed Web of Science ®Google Scholar
• Strengell M, Matikainen S, Siren J et al. IL-21 in synergy with IL-15 or IL-18 enhances IFN-γ production in human NK and T cells. J. Immunol.170(11), 5464–5469 (2003).
   PubMed Web of Science ®Google Scholar
• Kim HP, Korn LL, Gamero AM, Leonard WJ. Calcium-dependent activation of interleukin-21 gene expression in T cells. J. Biol. Chem.280(26), 25291–25297 (2005).
   PubMedGoogle Scholar
• Mehta DS, Wurster AL, Weinmann AS, Grusby MJ. NFATc2 and T-bet contribute to T-helper-cell-subset-specific regulation of IL-21 expression. Proc. Natl Acad. Sci. USA102(6), 2016–2021 (2005).
   PubMed Web of Science ®Google Scholar
• Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu. Rev. Immunol.27, 485–517 (2009).
   PubMed Web of Science ®Google Scholar
• Huber M, Brustle A, Reinhard K et al. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc. Natl Acad. Sci. USA105(52), 20846–20851 (2008).
   PubMed Web of Science ®Google Scholar
• Ho IC, Lo D, Glimcher LH. c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms. J. Exp. Med.188(10), 1859–1866 (1998).
   PubMed Web of Science ®Google Scholar
• Bauquet AT, Jin H, Paterson AM et al. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and Th-17 cells. Nat. Immunol.10(2), 167–175 (2009).
   PubMed Web of Science ®Google Scholar
• Asao H, Okuyama C, Kumaki S et al. Cutting edge: the common γ-chain is an indispensable subunit of the IL-21 receptor complex. J. Immunol.167(1), 1–5 (2001).
   PubMed Web of Science ®Google Scholar
• Spolski R, Leonard WJ. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol.26, 57–79 (2008).
   PubMed Web of Science ®Google Scholar
• Monteleone G, Pallone F, MacDonald TT. Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses. Trends Immunol.29(6), 290–294 (2008).
   PubMed Web of Science ®Google Scholar
• Jungel A, Distler JH, Kurowska-Stolarska M et al. Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis. Arthritis Rheum.50(5), 1468–1476 (2004).
   PubMed Web of Science ®Google Scholar
• Distler JH, Jungel A, Kowal-Bielecka O et al. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis. Arthritis Rheum.52(3), 856–864 (2005).
   PubMed Web of Science ®Google Scholar
• Monteleone G, Caruso R, Fina D et al. Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21. Gut55(12), 1774–1780 (2006).
   PubMed Web of Science ®Google Scholar
• Caruso R, Fina D, Peluso I et al. A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3a, by gut epithelial cells. Gastroenterology132(1), 166–175 (2007).
   PubMed Web of Science ®Google Scholar
• Ozaki K, Kikly K, Michalovich D, Young PR, Leonard WJ. Cloning of a type I cytokine receptor most related to the IL-2 receptor b chain. Proc. Natl Acad. Sci. USA97(21), 11439–11444 (2000).
   PubMed Web of Science ®Google Scholar
• Jin H, Carrio R, Yu A, Malek TR. Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis. J. Immunol.173(1), 657–665 (2004).
   PubMed Web of Science ®Google Scholar
• Zeng R, Spolski R, Casas E et al. The molecular basis of IL-21-mediated proliferation. Blood109(10), 4135–4142 (2007).
   PubMed Web of Science ®Google Scholar
• Fuqua CF, Akomeah R, Price JO, Adunyah SE. Involvement of ERK-1/2 in IL-21-induced cytokine production in leukemia cells and human monocytes. Cytokine44(1), 101–107 (2008).
   PubMedGoogle Scholar
• Spolski R, Leonard WJ. The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer. Curr. Opin. Immunol.20(3), 295–301 (2008).
   PubMed Web of Science ®Google Scholar
• Monteleone G, Monteleone I, Fina D et al. Interleukin-21 enhances T-helper cell type I signaling and interferon-γ production in Crohn’s disease. Gastroenterology128(3), 687–694 (2005).
   PubMed Web of Science ®Google Scholar
• Yamamoto-Furusho JK, Miranda-Perez E, Fonseca-Camarillo G et al. Interleukin 21 expression is increased in rectal biopsies from patients with ulcerative colitis. Inflamm. Bowel Dis.16(7), 1090 (2010).
   PubMedGoogle Scholar
• Sarra M, Monteleone I, Stolfi C et al. Interferon-g-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases. Inflamm. Bowel Dis. DOI: 10.1002/ibd.21238 (2010) (Epub ahead of print).
   Google Scholar
• van Heel DA, Franke L, Hunt KA et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat. Genet.39(7), 827–829 (2007).
   PubMed Web of Science ®Google Scholar
• Festen EA, Goyette P, Scott R et al. Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis. Gut58(6), 799–804 (2009).
   PubMedGoogle Scholar
• Asano K, Ikegami H, Fujisawa T et al. Molecular scanning of interleukin-21 gene and genetic susceptibility to type 1 diabetes. Hum. Immunol.68(5), 384–391 (2007).
   PubMed Web of Science ®Google Scholar
• Liu Y, Helms C, Liao W et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet.4(3), e1000041 (2008).
   PubMed Web of Science ®Google Scholar
• Chatterjee R, Batra J, Ghosh B. A common exonic variant of interleukin 21 confers susceptibility to atopic asthma. Int. Arch. Allergy Immunol.148(2), 137–146 (2009).
   PubMedGoogle Scholar
• Sawalha AH, Kaufman KM, Kelly JA et al. Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus. Ann. Rheum. Dis.67(4), 458–461 (2008).
   PubMed Web of Science ®Google Scholar
• Caruso R, Fina D, Peluso I et al. IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis. J. Immunol.178(9), 5957–5965 (2007).
   PubMedGoogle Scholar
• Fina D, Sarra M, Caruso R et al. Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut57(7), 887–892 (2008).
   PubMed Web of Science ®Google Scholar
• Fina D, Sarra M, Fantini MC et al. Regulation of gut inflammation and Th17 cell response by interleukin-21. Gastroenterology134(4), 1038–1048 (2008).
   PubMed Web of Science ®Google Scholar
• Caprioli F, Sarra M, Caruso R et al. Autocrine regulation of IL-21 production in human T lymphocytes. J. Immunol.180(3), 1800–1807 (2008).
   PubMed Web of Science ®Google Scholar
• Kwon JH, Keates S, Bassani L, Mayer LF, Keates AC. Colonic epithelial cells are a major site of macrophage inflammatory protein 3α (MIP-3α) production in normal colon and inflammatory bowel disease. Gut51(6), 818–826 (2002).
   PubMed Web of Science ®Google Scholar
• Wang C, Kang SG, Lee J, Sun Z, Kim CH. The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol.2(2), 173–183 (2009).
   PubMedGoogle Scholar
• Liu Z, Yang L, Cui Y et al. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease. Inflamm. Bowel Dis.15(8), 1133–1144 (2009).
   PubMed Web of Science ®Google Scholar
• Spolski R, Kim HP, Zhu W, Levy DE, Leonard WJ. IL-21 mediates suppressive effects via its induction of IL-10. J. Immunol.182(5), 2859–2867 (2009).
   PubMedGoogle Scholar
• Kishida T, Hiromura Y, Shin-Ya M et al. IL-21 induces inhibitor of differentiation 2 and leads to complete abrogation of anaphylaxis in mice. J. Immunol.179(12), 8554–8561 (2007).
   PubMed Web of Science ®Google Scholar
• Hiromura Y, Kishida T, Nakano H et al. IL-21 administration into the nostril alleviates murine allergic rhinitis. J. Immunol.179(10), 7157–7165 (2007).
   PubMed Web of Science ®Google Scholar
• Elsaesser H, Sauer K, Brooks DG. IL-21 is required to control chronic viral infection. Science324(5934), 1569–1572 (2009).
   PubMed Web of Science ®Google Scholar
• Andorsky DJ, Timmerman JM. Interleukin-21: biology and application to cancer therapy. Expert Opin. Biol. Ther.8(9), 1295–1307 (2008).
   PubMed Web of Science ®Google Scholar
• Sondergaard H, Coquet JM, Uldrich AP et al. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity. J. Immunol.183(11), 7326–7336 (2009).
   PubMedGoogle Scholar